Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Features

663 Features
Top ten talent issues for 2012

21 Dec 11

The integration of mobile technology, bilingual skills and the use of Recruitment Process Outsourcing for global expansion are amongst the top issues that will dominate China’s recruitment market in 2012, according to recruiting experts Hays.
Kathy Lou Marketing Manager, China HAYS Recruiting expert worldwide

Asia Pacific - A Resourcing Perspective

21 Dec 11

Building a team of suitably qualified clinical research professionals within the Asia Pacific region, particularly in China, South Korea, Taiwan and India, has become a critical requirement due to the enormous growth in clinical trial activity in the region.
Paula Mumby, Vice President, Operations, Asia Pacific

The End of the Sick note..?

09 Dec 11

It is estimated that long term sickness absence costs the UK economy almost £9 billion each year due to 140 million days lost as sickness absence. With an already failing economy, it is no wonder then that alongside a number of employment law reforms aimed at tackling the economic crisis, this is another area under scrutiny.
David Blomfield

What’s in it for you? Employers put the focus back on candidates trying to find their career path

05 Dec 11

Employee Value Propositions (EVP) and attractive incentives are once again in focus as employers consider candidates who have potential rather than solely those who are an exact fit for the role, says recruiting experts Hays.
HAYS

The Challenges of PharmacoVigilance

23 Nov 11

ABBYY and partner Document Genetics team up to streamline critical business processes
ABBYY

New data on UCB’s anti-TNF biologic Cimzia announced at American College of Rheumatology 2011 meeting

14 Nov 11

New data on UCB’s anti-TNF biologic certolizumab pegol (Cimzia), disclosed this week in several poster presentations during the annual meeting of the American College of Rheumatology (ACR), show the treatment works well in rheumatoid arthritis (RA) patients irrespective of prior exposure to other biologics, and that results are sustained over 28 weeks.
Olwen Glynn Owen - Pharmiweb Field Reporter

What's the Big iPad-ea?

01 Nov 11

We’re seeing increasing demand for pharma marketing solutions to be based on the iPad, and it’s not hard to see why. The pace at which the industry continues its move away from paper-based detail aids seems to be increasing. But what’s interesting is that remote ‘self-service’ edetailing does not seem to be growing at the same rate. The predicted disintermediation of the traditional field sales model hasn’t happened.
Paul Hartigan

CPL has got the stock under control

26 Oct 11

CPL Pharma Lager and Vertrieb GmbH designs and performs tailor-made logistics solutions for the healthcare and pharmaceutical industry throughout Germany and Austria.
Mark Hook, Ascent PR

Research Partnerships Set to Boost Clinical Trials

10 Oct 11

In the aftermath of last year’s inconclusive General Election — and the subsequent emergence of the Coalition Government — you’d have been forgiven for thinking that ‘deficit reduction’ was the only buzzword in town.
Max Golby

New Data Inspire Global Experts to Call for Improved Education, Awareness and Support for Head and Neck Cancer Patients

06 Oct 11

Merck Serono, a division of Merck KGaA, Darmstadt Germany, in partnership with the European Head and Neck Society (EHNS), will convene an expert panel of physicians, who will issue a call-to-action that will focus on providing tailored information, advice and better support networks to head and neck cancer patients.
Merck Serono

Working while on holiday-survey results

04 Oct 11

We recently ran a survey to ask people about the work they do when they are on vacation. It makes interesting reading!
Mike Wood

NICE - Analyst and Adviser Opportunities

03 Oct 11

NICE is a world-renowned, independent organisation responsible for providing national recommendations on the use of new and existing medicines and treatments within the NHS, through the Technology Appraisal Programme. The Scientific Advice Programme provides not-for-profit chargeable consulting services to companies who have products in development that may be referred for future evaluation by NICE.
NICE

European Multidisciplinary Cancer Congress (EMCC)

29 Sep 11

New drug formulations, biological agents, combination therapies and the latest pharmaceutical developments designed to improve outcomes in patients with a wide range of cancers were highlighted at EMCC 2001. Here are just a few of the highlights:
Stephen Pinn

UK Leads the Way with Embryonic Stem Cell Trial

26 Sep 11

Science is always at its most exciting when it looks to the far horizons. And the unavoidably controversial yet incredibly promising area of stem cell science provides arguably one of the most apt examples.
Max Golby

The Social Media effect on the Pharmaceutical & Healthcare Industry

20 Sep 11

Social media has probably become one of the most important forms of communication and interaction to date, and it is here to stay.
Burton Paul

America’s Pill Paucity

07 Sep 11

There’s a drugs shortage in America. That the construction of such a sentence is possible seems baffling for a nation that has led the world in medical innovation for decades.
Max Golby

What's NOT a domain name?

31 Aug 11

Esther Dyson the Great Dame of Silicon Valley, at times matriarch to Bill Gates and many other lads on the innovative circuit, wrote a harsh column August 26th on GPS CNN on ICANN gTLD. I like and respect Esther especially her technical background, we have shared the podium, but as this topic deals with the centrality of global corporate nomenclature it demands an authoritative analysis and I feel it’s my responsibility to clarify and taken the liberty to address her entire piece item by item.
Naseem Javed

Working while on Holiday?

25 Aug 11

How common is it to work during your vacation? - Take our short survey.
Mike Wood

The Proper Dose: Interviewing in the Pharmaceutical Industry

17 Aug 11

For recent graduates from science, medicine, or mathematics programs, applying for work in the ever-expanding pharmaceutical industry can be an intelligent choice for both career and financial stability. Depending on the industry upon which you choose to focus, the rules and expectations during the interview process can vary.
Terri Ingot

The Long-term Costs of Health Care

17 Aug 11

Almost irrespective of the country you live in, the increasing costs of healthcare are unavoidable. For governments, the stresses are particularly acute, as both aging populations and the increasing cost of treatments add financial pressures year on year. Yet as a new study by the Institute of Fiscal Studies (IFS) confirms, we should not underestimate the extent to which the shape of the state has already changed.
Max Golby - PharmiWeb Field Reporter

Let the jobs come to you!

04 Aug 11

Find out about the latest jobs that match your search - automatically.
Mike Wood

Vaccines and International Aid

27 Jun 11

At a moment when the national discourse on international aid is grounded in pessimism, David Cameron’s pledge to commit £814m to help vaccinate the world’s poorest children provides an necessary reminder of what international aid really can achieve.
Max Golby

Certolizumab works in RA regardless of prior TNF or concomitant DMARDs

31 May 11

Certolizumab pegol (Cimzia ®) delivered rapid and consistent improvements in a broad range of rheumatoid arthritis (RA) patients after 12 weeks of treatment regardless of whether or not they had received prior TNF inhibitors or whether or not they were receiving concomitant DMARDs, concluded the latest analysis of the Phase III b REALISTIC trial presented at the European League Against Rheumatism (EULAR) meeting in London, May 25-28 (abstract FRI021).
Janet Fricker

FDA set to approve Vertex Pharmaceuticals Inc.'s (VRTX) hepatitis C drug telaprevir and Merck’s hepatitis C drug, broceprevir.

10 May 11

Both drugs are protease inhibitors (PIs) and are designed to block an enzyme that helps the hepatitis C virus replicate. Hepatitis C is a liver disease caused by infection with the hepatitis C virus, which is transmitted through contaminated blood. The infection can cause liver failure and liver cancer.
Rhonda Siddall-Freelance Medical Journalist and Writer

Pharma Marketing: The Power of Taking Your Health Message Mobile

03 May 11

Brand managers and marketing leads are always striving to gain that first step of engagement, particularly in our world of pharmaceutical manufacturing. And with good reason. Customer engagement leads to improved understanding, which drives loyalty and ultimately improved health.
Eric Boothe, Director Business Development—Life Sciences

Candidate Tips – Your eMail Address

03 May 11

In competitive job searching, every little helps, and one thing that is often overlooked is your email address.
Mike Wood

Pharma on Twitter

14 Apr 11

Want to know which Pharma companies are on Twitter? - here's a list..
Mike Wood

The Code: What does it mean for you?

01 Apr 11

This week is Code Awareness Week and the Prescription Medicines Code of Practice Authority (PMCPA) is launching an e-learning module for health professionals
Claire Eldridge, Aurora

Competition in Healthcare

25 Mar 11

Since the very dawn of Western capitalism, competition has been synonymous with success. Indeed, in accounting for the past 500 years of Western ascendancy in the world, Professor Niall Ferguson of Harvard University points to six ‘killer apps’. The first of these, unsurprisingly, is competition
Max Golby

GSK sets new benchmark for graduate recruitment

17 Mar 11

Earlier this month the UK drugs giant GlaxoSmithKline announced a groundbreaking and progressive new scheme for graduates, whereby from 2012 the company will offer to reimburse in full the university tuition fees of the entirety its future graduate intake.
Max Golby

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.